Schonfeld Strategic Advisors LLC Arvinas, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 237,724 shares of ARVN stock, worth $6.31 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

237,724

Previous 281,097 15.43%

Holding current value

$6.31 Million

Previous $11.6 Million 45.46%

% of portfolio

0.04%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$24.46 - $40.4 $1.06 Million - $1.75 Million	-43,373 Reduced 15.43%	237,724 $6.33 Million
Q1 2024 May 15, 2024	BUY	$36.38 - $52.31 $1.28 Million - $1.84 Million	35,229 Added 14.33%	281,097 $11.6 Million
Q4 2023 Feb 14, 2024	BUY	$14.19 - $42.33 $2.58 Million - $7.7 Million	181,874 Added 284.2%	245,868 $10.1 Million
Q3 2023 Nov 14, 2023	SELL	$19.64 - $28.21 $35,469 - $50,947	-1,806 Reduced 2.74%	63,994 $1.26 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $1.43 Million - $2.07 Million	65,800 New	65,800 $1.63 Million
Q4 2022 Feb 14, 2023	SELL	$32.47 - $57.24 $84,746 - $149,396	-2,610 Reduced 16.95%	12,790 $437,000
Q3 2022 Nov 14, 2022	BUY	$41.87 - $57.99 $431,261 - $597,297	10,300 Added 201.96%	15,400 $685,000
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $183,651 - $378,624	5,100 New	5,100 $215,000
Q1 2022 May 16, 2022	SELL	$60.27 - $81.57 $168,756 - $228,395	-2,800 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$65.85 - $96.21 $251,020 - $366,752	-3,812 Reduced 57.65%	2,800 $230,000
Q3 2021 Nov 16, 2021	SELL	$73.2 - $107.87 $716,481 - $1.06 Million	-9,788 Reduced 59.68%	6,612 $543,000
Q2 2021 Aug 16, 2021	BUY	$60.45 - $84.26 $991,380 - $1.38 Million	16,400 New	16,400 $1.26 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $1.43 Million - $2.25 Million	-24,600 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$20.19 - $84.93 $3,856 - $16,221	-191 Reduced 0.77%	24,600 $2.09 Million
Q3 2020 Nov 16, 2020	BUY	$22.99 - $36.34 $422,602 - $668,001	18,382 Added 286.82%	24,791 $1,000
Q2 2020 Aug 14, 2020	BUY	$29.88 - $56.74 $191,500 - $363,646	6,409 New	6,409 $215,000
Q1 2020 May 15, 2020	SELL	$33.0 - $54.5 $457,446 - $755,479	-13,862 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$15.39 - $44.38 $349,937 - $1.01 Million	-22,738 Reduced 62.13%	13,862 $570,000
Q3 2019 Nov 14, 2019	SELL	$21.55 - $27.61 $928,805 - $1.19 Million	-43,100 Reduced 54.08%	36,600 $788,000
Q2 2019 Aug 14, 2019	BUY	$15.96 - $23.8 $1.27 Million - $1.9 Million	79,700 New	79,700 $1.75 Million
Q4 2018 Feb 14, 2019	SELL	$11.19 - $18.56 $223,800 - $371,200	-20,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.05 - $16.87 $321,000 - $337,400	20,000 New	20,000 $337,000

Others Institutions Holding ARVN

# of Institutions

223

Shares Held

68.6M

Call Options Held

166K

Put Options Held

31.3K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $1.41B
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Arvinas, Inc. Transaction History